Literature DB >> 1034027

[Considerations relating to multiple primary carcinomas of the urinary tract (author's transl)].

I Rovinescu, E Rousseau.   

Abstract

The patient with more than one primary malignant neoplasm has ceased to be a pathologic curiosity and has instead become a practical problem. It is possible for a patient to have two simultaneous developping independant cancers, but is also possible for a second primary cancer to develop in a cancer prone individual after the initial malignant lesion has been removed by radical surgical procedures. The generally improved survival rate after treatment of cancer has permitted more patients to live long enough for a second or even a third primary lesion to develop and it probably also reflects the more thorough pathological studies in both surgical and autopsy cases. It may be hoped that factors of genetic predisposition, ethiology and pathogenesis that are obscure in the patient with single lesions may be brought out in patients with multiple cancers. We present the case of a 83 years old patient with three different primary malignancies. His first tumour was a clear cell carcinoma of the left kidney at the age of 71, followed by a transitional cell carcinoma gr. II/IV of the bladder seven years later, and followed by a third one two and a half years latter which was a distinct adeno carcinoma of the prostate.

Entities:  

Mesh:

Year:  1976        PMID: 1034027

Source DB:  PubMed          Journal:  J Urol Nephrol (Paris)        ISSN: 0021-8200


  2 in total

Review 1.  The clear cell adenocarcinoma of the colon: case report and review of the literature.

Authors:  Chris Braumann; Michael Schwabe; Juergen Ordemann; Christoph A Jacobi
Journal:  Int J Colorectal Dis       Date:  2003-10-14       Impact factor: 2.571

2.  A novel combination of multiple primary carcinomas: urinary bladder transitional cell carcinoma, prostate adenocarcinoma and small cell lung carcinoma--report of a case and review of the literature.

Authors:  Anastassios V Koutsopoulos; Konstantina I Dambaki; George Datseris; Elpida Giannikaki; Marios Froudarakis; Efstathios Stathopoulos
Journal:  World J Surg Oncol       Date:  2005-07-26       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.